Evolution and Variations of the Ovine Model of Spina Bifida
Fetal Diagnosis and Therapy · 2023
DOI: 10.1159/000531750 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Fetal Diagnosis and Therapy, 2023. Verfasst von Su Yeon Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric General, Thoracic and Fetal Surgery, University of California Davis Medical Center, Sacramento, California, USA, suyle@ucdavis.…. Hauptthemen laut MEDLINE: Meningomyelocele, Spinal Dysraphism, Meningocele. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Spina bifida is the most common congenital anomaly of the central nervous system and the first non-fatal fetal lesions to be addressed by fetal intervention. While research in spina bifida has been performed in rodent, nonhuman primate, and canine models, sheep have been a model organism for the disease. This review summarizes the history of development of the ovine model of spina bifida, previous applications, and translation into clinical studies. Initially used by Meuli et al. [Nat Med. 1995;1(4):342–7], fetal myelomeningocele defect creation and in utero repair demonstrated motor function preservation. The addition of myelotomy in this model can reproduce hindbrain herniation malformations, which is the leading cause of mortality and morbidity in humans. Since inception, the ovine models have been validated numerous times as the ideal large animal model for fetal repair, with both locomotive scoring and spina bifida defect scoring adding to the rigor of this model. The ovine model has been used to study different methods of myelomeningocele defect repair, the application of various tissue engineering techniques for neuroprotection and bowel and bladder function. The results of these large animal studies have been translated into human clinical trials including Management of Meningocele Study (MOMS) trial that established current standard of care for prenatal repair of spina bifida defects, and the ongoing trials including the Cellular Therapy for In Utero Repair of Myelomeningocele (CuRe) trial using a stem cell patch for repair. The advancement of these life savings and life-altering therapies began in sheep models, and this notable model continues to be used to further the field including current work with stem cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric General, Thoracic and Fetal Surgery, University of California Davis Medical Center, Sacramento, California, USA, suyle@ucdavis.edu.
- Center for Surgical Bioengineering, University of California Davis, Sacramento, California, USA, suyle@ucdavis.edu.
- University of California Davis School of Medicine, Sacramento, California, USA.
- Division of Pediatric General, Thoracic and Fetal Surgery, University of California Davis Medical Center, Sacramento, California, USA.
- Center for Surgical Bioengineering, University of California Davis, Sacramento, California, USA.
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
Zitieren
APA
Lee, S. Y., Du, Y., Hassan, A. S., Brown, E., Saadai, P., Hirose, S., Wang, A., & Farmer, D. L. (2023). Evolution and Variations of the Ovine Model of Spina Bifida. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000531750
Vancouver
Lee SY, Du Y, Hassan AS, Brown E, Saadai P, Hirose S, et al. Evolution and Variations of the Ovine Model of Spina Bifida. Fetal Diagnosis and Therapy. 2023. doi:10.1159/000531750
BibTeX
@article{Lee2023,
author = {Lee, Su Yeon and Du, Yimeng and Hassan, Abd-Elrahman Said and Brown, Erin and Saadai, Payam and Hirose, Shinjiro and Wang, Aijun and Farmer, Diana L},
title = {Evolution and Variations of the Ovine Model of Spina Bifida},
journal = {Fetal Diagnosis and Therapy},
year = {2023},
doi = {10.1159/000531750}
}
EUVIMED